GABIPENTA-100

14% OFF

Original price was: ₹150.00.Current price is: ₹129.00.

GABIPENTA-100

Salt Composition: Gabapentin 100 mg (tablet, alu-alu).

Brand: Leeford

10.0 tablets in 1 strip

Buy Now
Category:

Description

GABIPENTA-100 contains gabapentin 100 mg per tablet. Gabapentin is an anticonvulsant and neuropathic pain medication prescribed for specific neurological and pain disorders.

Uses

  • Neuropathic pain: Treats chronic nerve pain caused by diabetes (diabetic neuropathy), shingles (postherpetic neuralgia), spinal cord injury, and other conditions.

  • Epilepsy: Used as adjunctive therapy for partial seizures and general seizure control in epilepsy.

  • Restless Legs Syndrome (RLS): Sometimes prescribed off-label or as an extended-release formulation for moderate-to-severe RLS.

  • Other off-label uses: Fibromyalgia, anxiety disorders, alcohol withdrawal, and certain psychiatric or chronic pain disorders (only under physician guidance).

How GABIPENTA-100 Works

Gabapentin calms overactive nerves in the brain and spinal cord by modulating neurotransmitter activity. It reduces abnormal electrical discharges in epilepsy and blocks pain signals through damaged nerves in neuropathic pain.

Common Side Effects

  • Sleepiness, dizziness, fatigue, headache

  • Viral or respiratory infections, fever, abnormal voluntary movements, visual disturbances, vertigo

  • Gastrointestinal upset (nausea, diarrhea), joint/muscle pain, decreased/increased appetite, impotence

Directions & Safety Advice

  • Take at the same time daily, preferably at bedtime to minimize daytime sedation.

  • Do not abruptly discontinue—may increase seizure risk.

  • Avoid alcohol and antacids around dosing time (may affect absorption).

  • Consult physician promptly for mood changes, suicidal thoughts, or unusual symptoms.

Availability and Regulatory Status in India

Gabapentin 100 mg tablets (GABIPENTA-100 and generics) are not banned in India. They are regularly prescribed, widely available from multiple pharmaceutical manufacturers, and included in standard treatment guidelines for epilepsy and neuropathic pain. There are no regulatory restrictions reported for gabapentin in India as of September 2025.

Leave a Reply

Your email address will not be published. Required fields are marked *